1. Greenlee RT, Murray T, Bolder S, Wingo PA: CA Cancer J Clin 2000, 50:7–33.
2. McGuire WP, Ozols RF: Chemotherapy of advanced ovarian cancer. Semin Oncol 1998, 25:340–348.
3. Ozols R, O’Dwyer P, Hamilton T: Clinical reversal of drug resistance in ovarian cancer. Gynecol Oncol 1993, 51:90–96.
4. Coukos G, Rubin SC: Chemotherapy resistance in ovarian cancer: new molecular perspectives. Obstet Gynecol 1998, 91:783–791. This paper provides information on the classic mechanisms of resistance in ovarian cancer. In addition, these authors discuss the apoptotic pathways and the role that molecular alterations in this pathway cause in the development of drug resistance.
5. Sood AK, Buller RE: Drug resistance in ovarian cancer: from the laboratory to the clinic. Obstet Gynecol 1998, 92:312–319.